Poster Abstracts4 New HIV specific latency reversing agents with novel targets that synergise with HIV Tat and the bromodomain inhibitor, JQ1 to reactivate HIV from primary cells.
Under a Creative Commons license
open access
Cited by (0)
Copyright © 2017 Elsevier B.V.